Back to News
Market Impact: 0.15

RIVN Quantitative Stock Analysis

RIVNNDAQ
Company FundamentalsAnalyst InsightsCorporate EarningsAutomotive & EVInvestor Sentiment & Positioning
RIVN Quantitative Stock Analysis

Validea's analysis of Rivian Automotive (RIVN) using Benjamin Graham's deep value investment strategy yielded a 57% rating, significantly below the 80% threshold for investor interest. As a large-cap growth stock, RIVN notably failed key Graham criteria including long-term EPS growth, P/E ratio, and Price/Book ratio, indicating it does not align with traditional deep value investment profiles despite passing some balance sheet health checks.

Analysis

Rivian Automotive (RIVN) scores a 57% on Validea's Value Investor model, based on Benjamin Graham's deep value strategy, a rating that falls significantly short of the 80% threshold required to signal strategist interest. The analysis reveals a fundamental mismatch between RIVN, a large-cap growth stock, and the criteria of a deep value screen. Specifically, RIVN fails on core valuation and profitability metrics, including long-term EPS growth, P/E ratio, and Price/Book ratio. These failures are critical as they form the foundation of the Graham methodology. While the company demonstrates balance sheet stability by passing tests for its current ratio and its ratio of long-term debt to net current assets, these solvency indicators are insufficient to compensate for the pronounced lack of historical profitability and the expensive valuation multiples from a value investing standpoint. The negative sentiment score of -0.5 for the ticker corroborates the unfavorable assessment based on these fundamental value metrics.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.20

Ticker Sentiment

NDAQ0.00
RIVN-0.50

Key Decisions for Investors

  • Deep value investors should view RIVN with significant caution, as its failure on foundational Graham metrics for valuation and long-term earnings indicates a clear misalignment with their strategy.
  • Investors should recognize that while RIVN passes on several balance sheet health checks, suggesting some operational liquidity, this must be weighed against its current lack of profitability and unfavorable valuation.
  • Growth-oriented investors should note that this specific analysis uses a value-centric lens, which may not capture catalysts relevant to a growth thesis, such as production scaling, market share gains, or future technology adoption.